Volume 13, Issue 5, Pages 1083-1087 (May 2016) Drug-induced Brugada syndrome: Clinical characteristics and risk factors  Maayan Konigstein, MD, Raphael Rosso, MD, Guy Topaz, MD, Pieter G. Postema, MD, Limor Friedensohn, MD, Karin Heller, MD, David Zeltser, MD, Bernard Belhassen, MD, Arnon Adler, MD, Sami Viskin, MD  Heart Rhythm  Volume 13, Issue 5, Pages 1083-1087 (May 2016) DOI: 10.1016/j.hrthm.2016.03.016 Copyright © 2016 Heart Rhythm Society Terms and Conditions

Figure 1 Distribution of ECG abnormalities. A: Classification of ECGS of patients with drug-induced Brugada syndrome recorded in the absence of drugs (red columns) and controls (blue columns). B: Classification of the same ECGs during simulated “preparticipation screening” by an expert in Brugada syndrome asked to report even subtle ECG abnormalities. See ECG analysis section for definition of ECG abnormalities. *P < .05; **P < .005. RBBB = right bundle branch block. Heart Rhythm 2016 13, 1083-1087DOI: (10.1016/j.hrthm.2016.03.016) Copyright © 2016 Heart Rhythm Society Terms and Conditions